Such a combination is not recommended by any current hypertension guidelines, because β‐blockers suppress renin secretion and reduce the plasma levels of angiotensin II and, therefore, perceived to be less additive in antihypertensive efficacy to ACEIs/ARBs.45 The gene discussed is AGT; the disease is hypertensive disorder.